# Neurotoxicity Evaluation of Beta-lactams in Intensive Care Unit and Identification of the Risk Factors

> **NCT03628300** · — · COMPLETED · sponsor: **Centre Hospitalier Universitaire, Amiens** · enrollment: 400 (actual)

## Conditions studied

- Neurotoxicity
- Sepsis
- Beta Lactams
- Therapeutic Drug Monitoring
- Critical Care
- Acute Kidney Injury

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03628300
- **Lead sponsor:** Centre Hospitalier Universitaire, Amiens
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2017-07-01
- **Final completion:** 2017-07-01
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2022-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03628300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03628300, "Neurotoxicity Evaluation of Beta-lactams in Intensive Care Unit and Identification of the Risk Factors". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03628300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*